You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • EP1269 Quality of life after surgery of varying surgical complexity in advanced ovarian cancer: results from the international, prospective, multicenter cohort SOCQER2 study

Article Text

Article menu
Download PDFPDF
ePoster
EP1269 Quality of life after surgery of varying surgical complexity in advanced ovarian cancer: results from the international, prospective, multicenter cohort SOCQER2 study
  1. S Sundar1,
  2. C Cummins2,
  3. S Kumar2,
  4. J Long3,
  5. V Arora4,
  6. J Balega3,
  7. T Broadhead5,
  8. T Duncan6,
  9. R Edmondson7,
  10. C Fotopoulou8,
  11. R Glasspool9,
  12. D Kolomainen10,
  13. S Leeson11,
  14. R Manchanda12,
  15. O McNally13,
  16. J Morrison14,
  17. A Mukhopadhyay15,
  18. J Paul16,
  19. J Tidy17 and
  20. N Wood18
  1. 1Institute of Cancer and Genomic Sciences University of Birmingham
  2. 2University of Birmingham Institute of Applied Health Research
  3. 3Institute of Applied Health Research, University of Birmingham, Birmingham, UK
  4. 4Bondi Women’s Health, Sydney, NSW, Australia
  5. 5Leeds Teaching Hospitals NHS Trust, Leeds
  6. 6Norfolk and Norwich University Hospital, Norwich
  7. 7University of Manchester, Manchester
  8. 8Imperial College London, London
  9. 9Institute of Clinical Sciences, University of Glasgow, Glasgow
  10. 10Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea
  11. 11Betsi Cadwaladr University Health Board, Bangor
  12. 12Barts Cancer Institute, London, UK
  13. 13Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
  14. 14Taunton and Somerset NHS Foundation Trust, Taunton, UK
  15. 15Tata Medical Center, Kolkata, India
  16. 16University of Glasgow, Glasgow
  17. 17University of Sheffield, Sheffield
  18. 18Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK

Abstract

Introduction/Background Extensive surgery has been shown in retrospective studies to improve survival from advanced ovarian cancer. UK uptake of extensive surgery has been variable, owing to concerns regarding the impact on quality of life (QoL) and organizational factors. We investigated QoL after surgery in parallel, multicentre, international, prospective cohorts, here reporting UK and Kolkata, India results.

Methodology Patients completed EORTC-QLQ-C30 and other Patient Reported Outcome Measures pre-operation and at 6 weeks, 6, 12, 18 and 24 month postoperatively. Surgical complexity scores (SCS), intraoperative disease load and survival up to two years were collected and Kaplan Meier survival analyses and forward stepwise Cox proportional hazard models of overall survival conducted. The association of SCS with QLQ-C30 global scores at 6 weeks, 6 months and 12 months post-surgery was evaluated using general linear repeated measures models (SPSS 24).

Results In 247 patients, those undergoing high (64) or intermediate (70) SCS procedures were younger, showed better performance status, higher disease load, more upper abdominal disease and greater cytoreduction rates although all SCS groups included patients with a higher burden of disease. (Table 1). Progression free and overall survival was poorer with residual disease in all SCS groups (log rank p≤0.001) (figure 1). Age Adjusted Charlson Comorbidity Index, pre-operative albumin and Peritoneal Carcinomatosis Index were independent predictors of survival (table 2). In a complete case analysis, post operation QLQ-C30 improved in all SCS groups between 6 weeks and 12 months (p<0.001) (figure 2) with no statistically significant or large differences between SCS groups over that time.

Conclusion In this observational study, QoL of patients improved postoperatively, and was no worse in patients undergoing complex surgery during that period. Extensive surgery to achieve complete cytoreduction for high disease load was associated with improved survival and no deleterious impact on QoL in the post operative year.

Disclosure Nothing to disclose

Abstract EP1269 Figure 1
Abstract EP1269 Figure 1

Survival by Surgical Complexity Score and by presence of residual disease

Abstract EP1269 Figure 2
Abstract EP1269 Figure 2

EORTC30 Global scores by surgical complexity score in patients without disease progression

View this table:
Abstract EP1269 Table 1

Patient characteristics by Surgical Complexity Score (SCS)

View this table:
Abstract EP1269 Table 2

Overall survival adjusted hazard ratios (Cox proportional hazards)

https://doi.org/10.1136/ijgc-2019-ESGO.1275

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.